No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
Scandinavian Medical Solutions A/S (SMS), a global entity established in 2018 and headquartered in Aalborg, Denmark, specializes in medical imaging equipment. The company provides a comprehensive array of diagnostic and therapeutic devices, encompassing CATH lab systems, CT scanners, linear accelerators, mammography units, PET/CT and SPECT/CT systems, X-ray machines, ultrasound equipment, MRI scanners, GAMMA/SPECT systems, C-arms, mobile X-ray units, R/F systems, and DEXA scanners, among others. Furthermore, SMS supplies critical spare parts for specific equipment types including CT, MRI, CATH lab, X-ray, mammography, PET/CT, and C-arm systems. Beyond sales, their offerings extend to equipment rental and technical support services. SMS serves a broad clientele, including hospitals, various medical clinics, and distributors worldwide.
www.scandinavian-medical.comNo one on the platform currently holds SMSMED.CO.
No tracked institution reports a position in SMSMED.CO as of their last filing.
No one on the platform has traded SMSMED.CO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 0.2% | — | — | — | ||
| Rev. Growth % | 8.3% | 42.4% | ||||
| Profit Margin % | 0.0% | 6.3% | ||||
| Free Cash Flow Margin % | -13.9% | -12.5% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $215M | -6.0% | $-0.10 | $-0.10–$-0.10 | — | 1 |
| 2027 | $267M | +24.4% | $0.20 | $0.20–$0.20 | — | 1 |
| 2028 | $312M | +16.7% | $0.45 | $0.45–$0.45 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 3 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-09-02 | $-0.10 | $-0.36 | -267.2% |
| 2026-02-25 | $0.20 | $0.09 | -57.3% |
| 2025-09-03 | $-0.08 | $-0.10 | -25.0% |
| -0.00% |
| $40M |
| — |
| VIRO.COViroGates A/S | $10.80 | +6.93% | $100M | — |
Source: Financial Modeling Prep · peers by sector/industry